SCHEMBL2597252

SCHEMBL2597252

COC(=O)c1ccc(O[C@H]2CCN(C3CCN(C(=O)OC(C)(C)C)CC3)C2=O)cn1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.51
FPR2 P25090 1/20 0.47
ALDH1A1 P00352 1/20 0.44
PIK3CA P42336 1/20 0.44
MTOR P42345 1/20 0.44
PRKDC P78527 1/20 0.44
CTSD P07339 1/20 0.44
CTSE P14091 1/20 0.44
BACE1 P56817 1/20 0.44
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.42
STS P08842 1/20 0.41
SRC P12931 1/20 0.41
USP30 Q70CQ3 2/20 0.40
NPBWR1 P48145 1/20 0.40
MCHR1 Q99705 1/20 0.40
NR3C1 P04150 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39
HCAR1 Q9BXC0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2597251 1.00 GPR119 (0.51) GPR119FPR2ALDH1A1PIK3CAMTOR
SCHEMBL797136 0.85 FPR2 (0.51) GPR119FPR2ALDH1A1CTSDCTSE
SCHEMBL21607020 0.84 GPR119 (0.58) GPR119ALDH1A1STSNPBWR1MCHR1
SCHEMBL30263276 0.84 GPR119 (0.58) GPR119ALDH1A1STSNPBWR1MCHR1
SCHEMBL789523 0.84 GPR119 (0.52) GPR119FPR2TP53CYP3A4
SCHEMBL789522 0.84 GPR119 (0.52) GPR119FPR2TP53CYP3A4
Hydrochloric Acid SCHEMBL2597010 0.83 PLAT (0.39) GPR119FPR2PIK3CAPRKDCMCHR1
Hydrochloric Acid SCHEMBL15022640 0.83 PLAT (0.39) GPR119FPR2PIK3CAPRKDCMCHR1
SCHEMBL25282448 0.80 GPR119 (0.54) GPR119ALDH1A1PIK3CAUSP30
SCHEMBL29212746 0.80 GPR119 (0.54) GPR119ALDH1A1PIK3CAUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754226-B2 Piperidinyl-substituted lactams as GPR119 modulators ARRAY BIOPHARMA INC. (US) 2014-06-17 US disclosed
US-20130158009-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA, INC. 2013-06-20 US disclosed
EP-2571864-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS Array Biopharma, Inc. (US) 2013-03-27 EP disclosed
WO-2011146335-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS ARRAY BIOPHARMA INC. (US) 2011-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158009-A1 PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS GPR119, GPR139, GPR39 GPR119 1/4885FPR2 328/4885ALDH1A1 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.